What is it about?
Diabetic neuropathies (DN) are the most common complications in diabetic patients, affecting about 70% of them. Patients with DN may lose sensation in certain areas of the body, facilitating the onset of foot ulcers, as well as chronic pain. This is due to the progressive degeneration of nerve fibers, demyelination, and axonopathy. In the present review, we attempt to discuss the potential of most studied types of stem cells, their application for the treatment of experimental diabetic neuropathies, and associated clinical manifestations including future perspectives around these themes.
Read the Original
This page is a summary of: Stem Cell Therapies for the Treatment of Diabetic Neuropathies: Future Perspectives, Current Diabetes Reviews, December 2020, Bentham Science Publishers, DOI: 10.2174/1573399816666200417121915.
You can read the full text:
The following have contributed to this page